Patients with high-grade non–muscle-invasive bladder cancer are a heterogeneous population.
Statistical models, such as the EORTC and CUETO ones, were developed to improve outcomes prediction.
Cell-cycle markers have been associated with outcomes after radical cystectomy.
Unfortunately these markers do not improve prediction at the time of TURBT.